Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07172438 · ClinicalTrials.gov registry record · NA
A RCT to Determine the Effect of ENDS Flavor Availability on Abstinence Within Smokers
A NA study, sponsored by RAI Services Company.
- Terminated
- Registry status
- NA
- Development phase
- 668
- Enrollment target
NCT07172438: Clinical Trial NA study, sponsored by RAI Services Company.
NCT07172438 is a NA study that was terminated before completion, run by RAI Services Company. The registered enrollment target is 668 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07172438, a NA study, was terminated before completion, sponsored by RAI Services Company.
- TERMINATED
- Registry status
- NA
- Development phase
- 668 participants
- Enrollment target
Study Summary
The overall purpose of this study will be to assess primary combustible cigarette users' abstinence from smoking their usual brand of combustible cigarettes at the end of the study, when provided with an electronic nicotine delivery system (ENDS) power unit (2) and varying levels of access to tobacco-flavored, menthol-flavored, or non-tobacco/non-menthol-flavored cartridge-based e-liquids (collectively referred to as the investigational product) within their assigned study arm over a three-month (ninety-day) period.
Primary Outcome
The odds (i.e., relative probabilities) of participants self-reporting 7-day point prevalence abstinence from combustible cigarette (CC) smoking, as recorded in an electronic diary (eDiary) during the final 7 days of the 13-week study period, comparing Study Arm 1 versus Study Arm 3, and Study Arm 2 versus Study Arm 3.
Interventions
- OTHER P2613422
- OTHER P2611222
- OTHER P2615122
- OTHER P2615022
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 668 participants |
| Start Date | 2025-09-17 |
| Est. Completion | 2026-01-14 |
| Phase | NA |
Why NCT07172438 stopped before completion
NCT07172438 is an interventional study that assigns participants to a tested intervention. The registered 668 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower).
The record links to 0 conditions, and to 4 interventions - of which P2613422 is the first listed.
NCT07172438 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07172438 about?
NCT07172438 is a clinical study titled "A RCT to Determine the Effect of ENDS Flavor Availability on Abstinence Within Smokers". The overall purpose of this study will be to assess primary combustible cigarette users' abstinence from smoking their usual brand of combustible cigarettes at the end of the study, when provided with an electronic nicotine delivery system (ENDS) power unit (2) and varying levels of access to tobacc...
What is the current status of trial NCT07172438?
This trial is currently terminated. It is a NA study. The enrollment target is 668 participants. The study started on 2025-09-17. Estimated completion is 2026-01-14.
What interventions are being tested in trial NCT07172438?
The interventions under investigation include: P2613422 (OTHER), P2611222 (OTHER), P2615122 (OTHER), P2615022 (OTHER).
Who is sponsoring clinical trial NCT07172438?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07172438's enrollment target sits among peer trials
668 154th of 2000 higher than 1,846 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04155034 · 668 participants · Phase 3
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer
- NCT04179981 · 668 participants · NA
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
- NCT05006482 · 668 participants · Phase 3
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
- NCT02984761 · 670 participants · NA
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI